Sulfalene

Sulfalene

SCHEMBL1893333

COc1nccnc1NS(=O)(=O)c1ccc(N)cc1.COc1nccnc1NS(=O)(=O)c1ccc(N)cc1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

folP

The experimentally established mechanism targets of Sulfalene. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 1.00
KMT2A Q03164 1/20 1.00
ESR1 P03372 1/20 0.69
GAA P10253 2/20 0.63
ALDH1A1 P00352 4/20 0.58
LMNA P02545 3/20 0.56
MAPT P10636 1/20 0.55
CCR4 P51679 3/20 0.53
ALOX12 P18054 2/20 0.53
AURKA O14965 1/20 0.53
DHFR P00374 1/20 0.53
TSHR P16473 1/20 0.53
SMN1; SMN2 Q16637 2/20 0.52
CYP2C19 P33261 2/20 0.52
PIK3C2B O00750 1/20 0.49
PIK3C2G O75747 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Sulfalene SCHEMBL28404 1.00 MEN1 (1.00) MEN1KMT2AESR1GAAALDH1A1
Sulfalene SCHEMBL3964512 0.95 MEN1 (0.90) MEN1KMT2AESR1GAAALDH1A1
Sulfalene SCHEMBL28086248 0.95 MEN1 (0.90) MEN1KMT2AESR1GAAALDH1A1
Sulfalene SCHEMBL3961075 0.93 KMT2A (0.87) MEN1KMT2AESR1GAAALDH1A1
Sulfadoxine SCHEMBL28122268 0.90 ESR1 (0.88) MEN1KMT2AESR1GAAALDH1A1
Sulfalene SCHEMBL28122260 0.87 KMT2A (0.76) MEN1KMT2AESR1GAAALDH1A1
Sulfalene SCHEMBL28766577 0.86 KMT2A (0.74) MEN1KMT2AESR1GAAALDH1A1
Sulfalene SCHEMBL28263603 0.86 MEN1 (0.74) MEN1KMT2AESR1GAAALDH1A1
SCHEMBL1095077 0.85 KMT2A (0.74) MEN1KMT2AESR1GAAALDH1A1
Sulfadimethoxine SCHEMBL28086139 0.84 ALDH1A1 (0.77) MEN1KMT2AESR1GAAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 45 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023123737-A1 MYCELIUM PACKAGING MATERIAL HAVING ANTI-COUNTERFEITING FUNCTION AND METHOD FOR USING SAME 深圳市泽青源科技开发服务有限公司 2023-07-06 WO claimed
US-11541069-B2 One or more HMOs for reducing or preventing fatigue and/or improving focus or concentration GLYCOM A/S (DK) 2023-01-03 US claimed
US-20210244777-A1 NOVEL BIFIDOBACTERIUM BACTERIA AND COMPOSITION INCLUDING NOVEL BIFIDOBACTERIUM BACTERIA MORINAGA MILK INDUSTRY CO., LTD. (JP) 2021-08-12 US claimed
WO-2024068747-A1 USES OF BIFIDOBACTERIUM LONGUM TRANSITIONAL MICROORGANISM Société des Produits Nestlé S.A. (CH) 2024-04-04 WO disclosed
EP-3488015-B1 HIGHLY POLYMORPHIC AND MODULAR EXTRAGENIC (H.P.M.E.) MARKERS WITHIN SPECIFIC TAXA OF MICROORGANISMS AND USE THEREOF FOR THEIR DIFFERENTIATION, IDENTIFICATION AND QUANTIFICATION MICROBION S R L (IT) 2024-02-21 EP disclosed
US-20240035098-A1 HIGHLY POLYMORPHIC AND MODULAR EXTRAGENIC (H.P.M.E.) MARKERS WITHIN SPECIFIC TAXA OF MICROORGANISMS AND USE THEREOF FOR THEIR DIFFERENTIATION, IDENTIFICATION AND QUANTIFICATION MICROBION S.R.L. (IT) 2024-02-01 US disclosed
WO-2024008851-A1 USES OF BIFIDOBACTERIUM LONGUM TRANSITIONAL MICROORGANISM Société des Produits Nestlé S.A. (CH) 2024-01-11 WO disclosed
WO-2023161444-A1 USES OF BIFIDOBACTERIUM LONGUM MICROORGANISMS HAVING THE CAPACITY TO DEGRADE BOTH HMO AND PLANT-DERIVED GLYCANS Société des Produits Nestlé S.A. (CH) 2023-08-31 WO disclosed
US-11730778-B2 Method of increasing the level and production of metabolized phytonutrients in a subject ACCESS BUSINESS GROUP INTERNATIONAL LLC (US) 2023-08-22 US disclosed
US-20230233626-A1 METHOD AND COMPOSITION FOR PRODUCTION OF A PHYTONUTRIENT IN A MICROBIOME ACCESS BUSINESS GROUP INTERNATIONAL LLC 2023-07-27 US disclosed
WO-2023123737-A1 MYCELIUM PACKAGING MATERIAL HAVING ANTI-COUNTERFEITING FUNCTION AND METHOD FOR USING SAME 深圳市泽青源科技开发服务有限公司 2023-07-06 WO disclosed
US-20160287677-A1 BACTERIAL ANTI-PHAGE DEFENSE SYSTEMS YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) 2016-10-06 US disclosed
US-9353359-B2 Bacterial anti-phage defense systems YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) 2016-05-31 US disclosed
WO-2016046294-A1 INFANT FORMULA SYSTEM WITH ADAPTIVE LEVELS OF HUMAN MILK OLIGOSACCHARIDES (HMOs) NESTEC S.A. (CH) 2016-03-31 WO disclosed
US-20160076013-A1 A MUTANT SIALIDASE HAVING TRANS-SIALIDASE ACTIVITY FOR USE IN PRODUCTION OF SIALYLATED GLYCANS DAIRY CREST LTD (GB) 2016-03-17 US disclosed
EP-2984104-A1 A MUTANT SIALIDASE HAVING TRANS-SIALIDASE ACTIVITY FOR USE IN PRODUCTION OF SIALYLATED GLYCANS Danmarks Tekniske Universitet (DK) 2016-02-17 EP disclosed
US-8889358-B2 Methods of amplifying a target sequence of a 16S rRNA or 16S rDNA in a prokaryotic species GENETIC ANALYSIS AS (NO) 2014-11-18 US disclosed
WO-2014167112-A1 A MUTANT SIALIDASE HAVING TRANS-SIALIDASE ACTIVITY FOR USE IN PRODUCTION OF SIALYLATED GLYCANS DANMARKS TEKNISKE UNIVERSITET (DK) 2014-10-16 WO disclosed
US-20140178353-A1 BACTERIAL ANTI-PHAGE DEFENSE SYSTEMS YEDA RESEARCH AND DEVELOPMENT CO., LTD. (IL) 2014-06-26 US disclosed
US-20110104692-A1 Oligonucleotide Primers GENETIC ANALYSIS AS (NO) 2011-05-05 US disclosed